ADM
28
3
MAR
63
-5
CL
54
3
XOM
42
-6
STT
64
2
DLTR
38
-4
EIX
70
3
THC
60
-5
GRMN
67
-4
T
48
3
ADSK
66
-4
LB
30
4
CNP
54
10
RIG
43
-7
BA
47
2
NOC
41
9
RHI
57
-6
ADP
65
-3
AN
50
-5
TROW
47
-6
ADM
28
3
MAR
63
-5
CL
54
3
XOM
42
-6
STT
64
2
DLTR
38
-4
EIX
70
3
THC
60
-5
GRMN
67
-4
T
48
3
ADSK
66
-4
LB
30
4
CNP
54
10
RIG
43
-7
BA
47
2
NOC
41
9
RHI
57
-6
ADP
65
-3
AN
50
-5
TROW
47
-6
Financhill
Back

Columbia Research Enhanced Rl Estt ETF Vs. Avidity Biosciences Industry Stock Comparison

Buy
60

CRED
Columbia Research Enhanced Rl Estt ETF

Last Price:
23.08
Seasonality Move:
12.14%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Buy
60
Columbia Research Enhanced Rl Estt ETF (CRED) is a Buy

Is Columbia Research Enhanced Rl Estt ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Rl Estt ETF [CRED] share price is $23.10. The Score for CRED is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • CRED is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRED Stock Price Chart

What is Columbia Research Enhanced Rl Estt ETF's stock price today?

  • The Columbia Research Enhanced Rl Estt ETF share price today is $23.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRED is experiencing slight buying pressure.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

CRED Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 43.11 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.19 - 23.89) Sell
Bollinger Bands (100): (21.71 - 23.85) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

CRED Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.2 Sell
20-day SMA: 23.45 Sell
50-day SMA: 23.62 Sell
200-day SMA: 21.62 Buy
8-day EMA: 23.21 Sell
20-day EMA: 23.36 Sell
50-day EMA: 23.32 Sell
200-day EMA: 21.98 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

Columbia Research Enhanced Rl Estt ETF Earnings Growth & CRED Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

Columbia Research Enhanced Rl Estt ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):